Mark Veich named chief organizational advancement officer of Parker Institute for Cancer Immunotherapy

Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer

Patricio M. Polanco, a surgical oncologist specializing in hepato-pancreato-biliary malignancies and minimally invasive and robotic liver and pancreas surgery, has joined Atrium Health as division chief of surgical oncology, surgeon-in-chief for Atrium Health Levine Cancer in Charlotte, North Carolina and inaugural Richard L. White Jr. Endowed Professor of Surgery at Wake Forest University School of Medicine.

July 24, 2026

Vol.52 No.29

News Analysis

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

On Feb. 2, Nature Medicine published the results of a large, randomized, prospective clinical trial in the nascent and some say, fringe, field of chrono-oncology—the study of how natural biological rhythms might impact cancer outcomes.

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

In Brief

David Gius assumes role of director of the University of Cincinnati Cancer Center

David Gius assumed the role of director of the University of Cincinnati Cancer Center, effective July 1.

July 02, 2026

Vol.52 No.26

In Brief

Kevin Becker named associate chief for MUSC Health Oncology ICCE

Kevin Becker was named the associate chief for the MUSC Health Oncology Integrated Center of Clinical Excellence.

June 26, 2026

Vol.52 No.25

In Brief

Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale

Ian E. Krop was named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs for Yale Cancer Center and Smilow Cancer Hospital.

June 18, 2026

Vol.52 No.24

Mark Veich named chief organizational advancement officer of Parker Institute for Cancer Immunotherapy

YOU MAY BE INTERESTED IN

Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

Ned Sharpless’s portrait unveiled at FNIH ceremony

David Gius assumes role of director of the University of Cincinnati Cancer Center

Kevin Becker named associate chief for MUSC Health Oncology ICCE

Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale

Renew today!

Subscriber content

Never miss an issue!

Login

Mark Veich named chief organizational advancement officer of Parker Institute for Cancer Immunotherapy

YOU MAY BE INTERESTED IN

Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

Ned Sharpless’s portrait unveiled at FNIH ceremony

David Gius assumes role of director of the University of Cincinnati Cancer Center

Kevin Becker named associate chief for MUSC Health Oncology ICCE

Ian Krop named section chief of Medical Oncology and Hematology and deputy director for Clinical Affairs at Yale

Never miss an issue!

Login

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.